Laparoscopic Enucleation of Frantz's Tumor of the Pancreas

Laparoscopic Enucleation of Frantz's Tumor of the Pancreas: Case Report and Literature Review

The present study describes a 32-year-old female patient, in whom a preoperative imaging diagnosis confirmed a mass in the junction of the body and tail of the pancreas. Based on the anamnesis, on the preoperative diagnosis, and on the general status of the patient, the decision was made to performed laparoscopic enucleation of the pancreatic tumor. The operation and postoperative recovery passed without complications. A minimally invasive surgical approach should be applied whenever the dimensions and the localization of the tumor permits it, bearing in mind all the benefits and advantages that this surgical technique has to offer.

Study Overview

• Status: Completed
• Conditions: Solid Pseudopapillary Neoplasm of the Pancreas
• Intervention / Treatment: Procedure: Enucleation of a tumor of the pancreas

• Study Type: Observational
• Enrollment (Actual): 1

Contacts and Locations

Study Locations

• Mexico
  • Nuevo Leon
    • Monterrey, Nuevo Leon, Mexico, 76140
      • Escuela Nacional de Medicina, Tecnologico de Monterrey

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 100 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

• Sampling Method: Non-Probability Sample

Study Population

Patients with a diagnosed pancreatic tumor by image study.

Description

Inclusion Criteria:

• Patients with benign tumor of the pancreas
• Patients with a size tumor of less than 3 cm on the pancreas

Exclusion Criteria:

• Patients with a size tumor greater than 3 cm on the pancreas
• Malignant tumors of the pancreas

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Complete enucleation of a tumor in the pancreas	Performance of a laparoscopic enucleation of a tumor in the pancreas, and compared it with a conventional approach	December 2020

Collaborators and Investigators

• Sponsor: Tecnologico de Monterrey

Study record dates

Study Major Dates

• Study Start (Actual): December 1, 2020
• Primary Completion (Actual): January 1, 2021
• Study Completion (Actual): January 2, 2021

Study Registration Dates

• First Submitted: January 21, 2021
• First Submitted That Met QC Criteria: January 25, 2021
• First Posted (Actual): January 28, 2021

Study Record Updates

• Last Update Posted (Actual): January 28, 2021
• Last Update Submitted That Met QC Criteria: January 25, 2021
• Last Verified: January 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Digestive System Diseases; Neoplasms; Neoplasms by Site; Endocrine System Diseases; Digestive System Neoplasms; Endocrine Gland Neoplasms; Pancreatic Diseases; Pancreatic Neoplasms; Gastrointestinal Agents; Pancrelipase
• Other Study ID Numbers: FT7831

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No